Novo Nordisk ' s stock rose during today ' s Wednesday dealings, following investors ' optimism about the prospects for sales of Wijoffi ' s real estate during the third quarter, boosting prospects for the growth of global demand for underweight medicines. The Frankfort stock climbed by 4.65% at 282.75 kroner, while New York Stock Exchange certificates jumped by 6% before the opening of the US market.